Perbedaan Galva Technologies Tbk. dan Organon Pharma Indonesia Tbk.: Galva Technologies Tbk. diperdagangkan di Rp326 (kapitalisasi pasar 492 M, volume 24 jam 3,8 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Galva Technologies Tbk. jauh lebih besar — sekitar 4,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GLVA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 492 M | 104,4 M |
Volume | 3,8 rb | — |
Lot | 38 | — |
Perputaran | 1,23 jt | — |
Harga Rata-rata | 322,53 | — |
Nilai Transaksi | 1,23 jt | — |
Harga Ekuilibrium Indikatif | 328 | — |
Volume Ekuilibrium Indikatif | 200 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Galva Technologies Tbk (the “Company”) was established under the Deed No. 1 dated September 1, 1991 by notary Fransiscus Jacobus Mawati, S.H., notary in Jakarta.
Selengkapnya di halaman GLVA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →